How do I dilute a vial of nitroglycerin and what is the recommended rate of infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin IV Dilution and Infusion Protocol

To administer intravenous nitroglycerin, dilute the vial in D5W or 0.9% saline to a concentration of 100 mcg/mL, and initiate infusion at 5 mcg/min, titrating by 5 mcg/min every 3-5 minutes until desired response is achieved, using non-absorbing tubing with an infusion pump.

Dilution Instructions

Initial Dilution

  1. Use only glass bottles of D5W or 0.9% Normal Saline for dilution
  2. Standard concentration:
    • Add 50 mg nitroglycerin to 500 mL of solution = 100 mcg/mL
    • Alternative: Add 5 mg nitroglycerin to 100 mL = 50 mcg/mL

Important Preparation Notes

  • NEVER administer undiluted nitroglycerin directly
  • Use only non-absorbing (non-PVC) tubing for administration 1
  • Do not mix nitroglycerin with other medications
  • Invert glass bottle several times to ensure uniform dilution
  • Higher concentrations (up to 400 mcg/mL) may be used to limit fluid administration 1

Administration Protocol

Initial Dosing

  • Start at 5 mcg/min using an infusion pump capable of exact delivery 1
  • For acute coronary syndromes or pulmonary edema: Begin with 5-10 mcg/min 2
  • For hypertensive emergencies: Begin with 5 mcg/min 2

Titration

  • Increase by 5 mcg/min every 3-5 minutes until clinical response 2, 1
  • If no response at 20 mcg/min, increase by 10 mcg/min increments
  • Once partial response is observed, reduce increment size and increase interval between adjustments 1

Target Endpoints

  1. Relief of symptoms (chest pain, pulmonary edema)
  2. Blood pressure response:
    • Decrease mean arterial pressure by 10% in normotensive patients
    • Decrease by up to 30% in hypertensive patients
    • Never reduce systolic BP below 90 mmHg 2
  3. Heart rate increase <10 beats/min (not exceeding 110 beats/min)
  4. Decrease in pulmonary artery end-diastolic pressure by 10-30% 2

Clinical Considerations

Dosing Cautions

  • Doses >200 mcg/min increase risk of hypotension; consider alternative therapy 2
  • Some patients (especially those with normal LV filling pressures) may be hypersensitive to nitroglycerin and respond to doses as low as 5 mcg/min 1
  • Prolonged infusion (>24 hours) may lead to tolerance 2, 3

Monitoring Requirements

  • Continuous blood pressure monitoring
  • ECG monitoring for heart rate changes
  • Monitor for headache (common side effect)
  • For high doses or prolonged use, consider arterial line placement 2

Special Situations

  • Avoid in patients with:
    • Systolic BP <90 mmHg
    • Severe bradycardia (<50 bpm)
    • Right ventricular infarction
    • Concurrent phosphodiesterase inhibitor use (sildenafil, tadalafil, vardenafil) 2

Infusion Rate Calculation

For a 100 mcg/mL concentration:

  • 5 mcg/min = 3 mL/hr
  • 10 mcg/min = 6 mL/hr
  • 50 mcg/min = 30 mL/hr
  • 100 mcg/min = 60 mL/hr

Remember that the actual delivered dose may vary based on tubing type. Non-absorbing tubing delivers more medication to the patient than PVC tubing, requiring lower doses 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Angina Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.